finding,pubmed_id,finding_id
"The study found that amphotericin B (AMB) prevents the antiviral actions of interferon-induced transmembrane proteins (IFITMs) and alleviates the symptoms of influenza infection in mice, suggesting that patients receiving amphotericin B formulations may be at greater risk for influenza.",PMC3898084,PMC3898084_0
"The study found that cholesterol and acetylcholine (ACH) enhance the antiviral actions of IFITMs and alleviate the symptoms of influenza infection in mice, suggesting that patients receiving cholesterol and/or ACHE formulations may have improved outcomes from influenza infection.",PMC3898084,PMC3898084_1
"The study found that vapa (VP) and ACHE prevent the antiviral actions of IFITMs and alleviate the symptoms of influenza infection in mice, suggesting that patients receiving VP and/or ACHE formulations may have improved outcomes from influenza infection.",PMC3898084,PMC3898084_2
"The study found that the vascular endothelial growth factor (VEGF) antagonist TNP (2-methoxy-1-[4-(2-methoxyphenoxy)butan-1-yl]-1H-1-naphthalen-1-yl)-3-[1-methoxy-1-[4-(2-methoxyphenoxy)butan-1-yl]-1H-1-naphthalen-1-yl]-1,3-[1-methoxy-1-[4-(2-methoxyphenoxy)butan-1-yl]-1H-1-naphthalen-1-yl]-1,3-[1-methoxy-1-[4-(2-methoxyphenoxy)butan-1-yl]-1H-1-naphthalen-1-yl]-1,3-[1-methoxy-1-[4-(2-methoxyphenoxy)butan-1-yl]-1H-1-naphthalen-1-yl]-1,3,5-[1-methoxy-1-[4-(2-methoxyphenoxy)butan-1-yl]-1H-1-naphthalen-1",PMC3898084,PMC3898084_3
